https://www.live-feeds.com/feed/fda-approves-updated-covid-19-vaccines-for-dominant-xfg-variantContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/fda-approves-updated-covid-19-vaccines-for-dominant-xfg-varianthttps://www.live-feeds.com/feed/fda-approves-updated-covid-19-vaccines-for-dominant-xfg-variant#u54975Wed, 02 Sep 2026 14:06:00 +0000The US FDA has approved updated Covid-19 vaccines from Moderna, Pfizer-BioNTech, and Novavax-Sanofi for the 2026-27 season to target the dominant XFG variant. The vaccines are expected to arrive at pharmacies and hospitals within days, allowing manufacturers to begin shipping doses as cases rise. Uncertainty remains regarding insurance coverage for the updated doses.Why it mattersThe approval of updated Covid-19 vaccines is crucial in addressing the rising cases and protecting vulnerable populations. The XFG variant, also known as Stratus, is currently dominant, and targeting it with updated v https://www.live-feeds.com/feed/fda-approves-updated-covid-19-vaccines-for-dominant-xfg-varianthttps://www.live-feeds.com/feed/fda-approves-updated-covid-19-vaccines-for-dominant-xfg-variant#u51147Sat, 29 Aug 2026 01:46:27 +0000The US Food and Drug Administration approved updated Covid-19 vaccines for the 2026-27 season to target the dominant XFG variant, also known as Stratus. Approved shots from Moderna, Pfizer-BioNTech, and Novavax-Sanofi are expected to arrive at pharmacies and hospitals within days. The decision allows manufacturers to begin shipping doses as cases rise. While the vaccines are ready for distribution, some uncertainty remains regarding how insurance providers will cover the costs of these updated doses.Why it mattersAnnual vaccine updates are necessary to address mutating strains of the virus. Th